Abstract
The intrathoracic blood volume is usually measured clinically by transpulmonary thermodilution (PiCCO system; Pulsion Ltd). New software also allows measurement at the bedside by lithium dilution (LiDCO system; LiDCO Ltd). We sought to compare the new lithium dilution method with the existing method.
Highlights
It has been previously shown that the two forms of acute cholecystitis, acute acalculous cholecystitis (AAC) and acute calculous cholecystitis (ACC), have significantly different histopathological features suggesting that AAC is a manifestation of systemic critical illness whereas ACC is a local disease of the gallbladder
Our preliminary results show that the CritiView may be a useful tool for the detection of O2 imbalance and the development of an emergency metabolic state in nonvital tissues
Age and ventilator time during first admission were significant predictors, corrected for patient characteristics
Summary
It has been previously shown that the two forms of acute cholecystitis, acute acalculous cholecystitis (AAC) and acute calculous cholecystitis (ACC), have significantly different histopathological features suggesting that AAC is a manifestation of systemic critical illness whereas ACC is a local disease of the gallbladder. The aim of this study was to find the incidence, risk factors and microbiological and clinical outcome of patients infected with ESBL producing Escherichia coli and Klebsiellae in the ICU of a tertiary care cardiac center in India. The aim of this study was to assess the relationship between blood glucose levels and clinical outcome in a mixed cohort of critically ill patients with a nosocomial bloodstream infection (BSI). The objective of this study was to investigate whether continuous glucose monitoring for intensive care patients could be implemented using blood microdialysis (MD) as tight glycaemic control reduces mortality and morbidity of critically ill patients. Aging is associated with decreased cardiopulmonary and renal reserve as well as the development of progressive organ failure
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.